Esomifyl Lyophilized Powder
Marketer
Leeford Healthcare Ltd
Salt Composition
Esomeprazole (40mg/10ml)
Overview Esomifyl Lyophilized Powder
Esomifyl Lyophilized Powder, a proton pump inhibitor (PPI), diminishes gastric acid secretion. It's indicated for stomach and intestinal disorders stemming from excess acid, including acid reflux and other related conditions. This injectable medication is also prophylactic against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Administered intravenously by a medical professional, it's reserved for patients where injection is deemed preferable to oral medication by their physician. Dosage and treatment length are determined by individual needs and response. Lifestyle modifications, such as frequent, smaller meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment effectiveness. Common, generally mild, side effects may include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome side effects warrant medical attention. Proactive bone health measures, such as calcium and vitamin D supplementation, are recommended. Prior to receiving Esomifyl Lyophilized Powder, inform your doctor of any severe liver impairment, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals should also seek medical counsel. Alcohol consumption should be avoided due to its potential to exacerbate symptoms by stimulating acid production.
Primary Ingredients of Esomifyl Lyophilized Powder
No text provided. Please provide the text you wish me to rephrase.
Uses of Esomifyl Lyophilized Powder
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Esomifyl Lyophilized Powder:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Esomifyl Lyophilized Powder:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esomifyl Lyophilized Powder:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Esomifyl Lyophilized Powder works:
Esomifyl, in its lyophilized form, functions as a proton pump inhibitor, decreasing gastric acid production to alleviate symptoms of acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Esomifyl Lyophilized Powder. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Esomifyl Lyophilized Powder during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lyophilized Esomifyl powder likely poses a breastfeeding safety risk. Available human data indicate potential transfer to breast milk, possibly harming the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esomifyl Lyophilized Powder on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with severe kidney impairment should use Esomifyl Lyophilized Powder cautiously, potentially requiring a modified dosage. Mild to moderate kidney disease does not necessitate dosage alteration. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Esomifyl Lyophilized Powder cautiously, potentially requiring dosage modification. Consult your physician for guidance. Dosage alteration is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Esomifyl Lyophilized Powder :
Omit a dose of Esomifyl Lyophilized Powder? Seek medical advice immediately.
Facts to Know About Esomifyl Lyophilized Powder
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Behavior Class | Gastric acid suppressants |


